Company Interview / Broker Moves | CBA, Xero, Orica, Lynas

The broker says this reflects a broader challenge of weak productivity growth in Australia. This could in turn constrain economic growth.

Morningstar has added that CBA is "just priced for too much" compared to peers.

Both Jefferies and Morningstar are flagging customer growth risks for Xero.

The brokers says customer growth is being impacted by price hikes, and noted the difficulty to win new customers in a mature ANZ market. 

Jefferies has cut its price target to $135.50 per share, while retaining it's 'hold' rating.

However, Citi has retained its 'buy' on Xero, with potential US upsides following the Melio acquisition.

Elsewhere - UBS, Macquarie and Bell Potter have all raised their target prices on Orica... attached with 'buy' and 'outperform' ratings.

Bell Potter expects multiple tailwinds, such as continued contract benefits, strong sodium cyanide demand, and expanding exploration activity.

It has a 'buy' on the stock, with a $26 target price.

And Macquarie has upgraded Lynas Rare earths from neutral to 'outperform', following recent share price weakness.

The broker says that demand remains "solid" and has set its target price on Lynas to $17